Pharmaceutical intervention of advanced glycation endproducts

Novartis Foundation Symposium

Volumn 235, Issue , 2001, Pages 202-216

  Cerami, Anthony ^a   Ulrich, Peter ^a  

^a Kenneth S Warren Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; N PHENACYLTHIAZOLIUM BROMIDE; N-PHENACYLTHIAZOLIUM BROMIDE; THIAZOLE DERIVATIVE;

ANIMAL; GLYCATION; HUMAN; METABOLISM; REVIEW;

ANIMALS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MAILLARD REACTION; THIAZOLES;

EID: 0035227858     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (36)

1. Asif M, Egan J, Vasan S et al 2000 An AGE cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci USA 97:2809-2813
2. Brown CD, Zhao ZH, De Alvaro F, Chan S, Friedman EA 1993 Correction of erythrocyte deformability defect in ALX-induced diabetic rabbits after treatment with aminoguanidine. Diabetes 42:590-593
3. Brownlee M, Pongor S, Cerami A 1983 Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes. J Exp Med 158:1739-1744
4. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A 1986 Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 232:1629-1632
5. Bucala R, Cerami A 1992 Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 23:1-34
6. Bucala R, Vlassara H, Cerami A 1992 Advanced glycosylation endproducts. In: Harding JJ, Crabbe C (eds) Post-translational modifications of proteins. CRC Press, Boca Raton, FL, p 53-79
7. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H 1993 Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438
8. Cerami A 1985 Accumulation of advanced glycosylation endproducts on proteins and nucleic acids: role in ageing. Prog Clin Biol Res 195:79-88
9. Ellis EN, Good BH 1991 Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus. Metabolism 40:1016-1019
10. Esposito C, Gerlach H, Brett J, Stern D, Vlassara H 1989 Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170:1387-1407
11. Farmar JG, Ulrich PC, Cerami A 1988 Novel pyrroles from sulfite-inhibited Maillard reactions: insight into the mechanism of inhibition. J Org Chem 53:2346-2349
12. Goldstein JL, Ho YK, Basu SK, Brown MS 1979 Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76:333-337
13. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M 1991 Ammoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 88:11555-11558
14. Harding JJ 1973 Disulfide cross-linked protein of high molecular weight in human cataractous lens. Exp Eye Res 17:377
15. Horiuchi S, Araki N, Morino Y 1991 Immunochemical approach to characterize advanced glycation endproducts of the Maillard Reaction. Evidence for the presence of a common structure. J Biol Chem 266:7329-7332
16. Huijberts MSP, Wolffenbuttel BHR, Struijker-Boudier HAJ et al 1993 Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J Clin Invest 92:1407-1411
17. Kihara M, Schmelzer JD, Poduslo JF, Curran GL, Nickander KK, Low PA 1991 Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals. Proc Natl Acad Sci USA 88:6107-6111
18. 1C and diabetes mellitus. Annu Rev Med 31:29-34
19. 1C in diabetes mellitus. N Engl J Med 295:417-420
20. 1C. J Biol Chem 252:2992-2997
21. Larsen ML, Horder M, Mogensen EF 1990 Effect of long-term monitoring of glycosylated hemogloblin levels in insulin-dependent diabetes mellitus. N Eng J Med 323:1021-1025
22. Makita Z, Vlassara H, Cerami A, Bucala R 1992 Immunochemical detection of advanced glycosylation endproducts in vino. J Biol Chem 267:5133-5138
23. Miyata S, Monnier V 1992 Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline. J Clin Invest 89:1102-1112
24. Monnier VM, Cerami A 1981 Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. Science 211:491-493
25. Monnier VM, Cerami A 1983 Detection of nonenzymatic browning products in the human lens. Biochim Biophys Acta 760:97-103
26. Monnier VM, Stevens VJ, Cerami A 1979 Nonenzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins in experimental sugar cataracts. J Exp Med 150:1098-1107
27. Monnier VM, Kohn RR, Cerami A 1984 Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 81:583-587
28. Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR 1986 Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Eng J Med 314:403-408
29. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H 1991 Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodeling and diabetic nephropathy. J Exp Med 174:931-939
30. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G 1991 Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 40:1328-1334
31. Vasan S, Zhang X, Zhang X et al 1996 An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382:275-278
32. Vitek MP, Bhattacharya K, Glendening JM et al 1994 Advanced glycation end products contribute to amyloidosis in Alzheimer's Disease. Proc Natl Acad Sci USA 91:4766-4770
33. Vlassara H, Brownlee M, Manogue R, Dinarello CA, Pasagian A 1988 Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 240:1546-1548
34. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R 1992 Exogenous advanced glycosylation endproducts induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA 89:12043-12047
35. Vlassara H, Bucala R, Striker L 1994 Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest 70:138
36. Wolffenbuttel BHR, Boulanger CM, Crijns FRL et al 1998 Breakers of advanced glycation endproducts restore large artery properties in experimental diabetes. Proc Natl Acad Sci USA 95:4630-4634